320 Phase IIa study of alpha-DC1 vaccine against HER2/HER3, chemokine modulation regimen and pembrolizumab in patients with asymptomatic brain metastasis from triple negative or HER2+ breast cancer

Bibliographic Details
Main Authors:	Pawel Kalinski, Peter Forsyth, Mateusz Opyrchal, Hung Khong, Amy Early, Brian Czerniecki, Shipra Gandhi, Kamran Ahmed, Kristopher Attwood, Ellis Levine, Tracey O’Connor, Robert Fenstermaker, Dheerendra Prasad, Kazuaki Takabe
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items